Chemocentryx Z Score

CCXI -  USA Stock  

USD 22.79  0.74  3.36%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Chemocentryx Piotroski F Score and Chemocentryx Valuation analysis.
Chemocentryx Invested Capital is most likely to increase significantly in the upcoming years. The last year's value of Invested Capital was reported at 383.12 Million. The current Invested Capital Average is estimated to increase to about 432.6 M, while Capital Expenditure is projected to decrease to (19.5 M). Chemocentryx Operating Expenses is most likely to increase significantly in the upcoming years. The last year's value of Operating Expenses was reported at 161.84 Million. The current Revenues is estimated to increase to about 37.1 M, while Consolidated Income is projected to decrease to (135.2 M).

Chemocentryx Z Score Analysis

Chemocentryx's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2019 2020 2021 2022 (projected)
Interest Expense2.15 M2.64 M2.69 M2.91 M
Gross Profit36.13 M64.89 M31.92 M36.96 M
Z Score 
Sum Of  
5 Factors 
More About Z Score | All Equity Analysis

Current Chemocentryx Z Score

Most of Chemocentryx's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemocentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
1.2 * (
Working Capital
Total Assets )
Second Factor
1.4 * (
Retained Earnings
Total Assets )
Thrid Factor
3.3 * (
Total Assets )
Fouth Factor
0.6 * (
Market Value of Equity
Total Liabilities )
Fifth Factor
0.99 * (
Total Assets )

Chemocentryx Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Chemocentryx is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Chemocentryx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemocentryx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemocentryx's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

In accordance with the company's disclosures, Chemocentryx has a Z Score of 2.3. This is 65.93% lower than that of the Healthcare sector and 31.14% lower than that of the Biotechnology industry. The z score for all United States stocks is 73.62% higher than that of the company.

Chemocentryx Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemocentryx's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemocentryx could also be used in its relative valuation, which is a method of valuing Chemocentryx by comparing valuation metrics of similar companies.
Chemocentryx is currently under evaluation in z score category among related companies.

Chemocentryx Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chemocentryx from analyzing Chemocentryx's financial statements. These drivers represent accounts that assess Chemocentryx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemocentryx's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee270.59 K(499.55 K)(676.7 K)(415.07 K)(477.33 K)(515.02 K)
Revenue Per Employee1.25 M564.14 K440.58 K486.57 K437.91 K425.21 K
Average Assets152.54 M190.61 M223.14 M447.82 M461.82 M498.28 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA18.28 M(36.23 M)(51.7 M)(49.95 M)(124.34 M)(127.61 M)
Earnings Before Interest Taxes and Depreciation Amortization USD18.28 M(36.23 M)(51.7 M)(49.95 M)(124.34 M)(127.61 M)
Earnings before Tax17.86 M(37.97 M)(55.49 M)(55.36 M)(131.75 M)(135.22 M)
Average Equity50.95 M22.66 M69.99 M317.93 M323.32 M348.85 M
Enterprise Value272.2 M541.85 M2.29 B4.29 B2.53 B1.99 B
Free Cash Flow4.16 M15.6 M(70.91 M)(96.55 M)(94.64 M)(97.13 M)
Invested Capital121.05 M110.52 M131.18 M498.12 M383.12 M413.37 M
Invested Capital Average87.97 M98.42 M135.44 M323.79 M400.92 M432.58 M
Market Capitalization290.16 M551.24 M2.3 B4.29 B2.55 B2.02 B
Tangible Asset Value189.33 M183.31 M209.08 M518.9 M425.65 M342.64 M
Working Capital146.89 M116.99 M115.28 M390.01 M206.16 M188.55 M

Chemocentryx Institutional Holders

Institutional Holdings refers to the ownership stake in Chemocentryx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemocentryx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemocentryx's value.
Security TypeSharesValue
Fmr LlcCommon Shares10.6 M266.5 M
Vanguard Group IncCommon Shares5.1 M128.3 M
Blackrock IncCommon Shares4.3 M107.7 M
State Street CorpCommon Shares3.6 M91.3 M
Pictet Asset Management SaCommon Shares1.8 M46.1 M
Perceptive Advisors LlcCommon Shares1.7 M41.5 M
Invesco LtdCommon Shares1.6 M40.4 M

Chemocentryx Fundamentals

About Chemocentryx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemocentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemocentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemocentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 178 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemocentryx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now


Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Chemocentryx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemocentryx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemocentryx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemocentryx to buy it.
The correlation of Chemocentryx is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemocentryx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemocentryx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemocentryx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Chemocentryx Piotroski F Score and Chemocentryx Valuation analysis. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Chemocentryx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemocentryx. If investors know Chemocentryx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemocentryx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.